brain

Angela Jefferson, PhD, and colleagues are establishing an Alzheimer’s Disease Research Center at VUMC.
September 10, 2020

VUMC to lay groundwork for Tennessee’s first federally funded Alzheimer’s Disease Research Center

Angela Jefferson, PhD, professor of Neurology and director of the Vanderbilt Memory and Alzheimer’s Center, has been awarded a $3.7 million, three-year grant from the National Institute on Aging (NIA) to support establishment of a prospective NIA-funded Alzheimer’s Disease Research Center (ADRC) at Vanderbilt University Medical Center.

By Paul Govern
September 3, 2020

New clue to Alzheimer’s disease

Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease.

By Bill Snyder
August 6, 2020

Grant supports research on abnormal brain aging

With the aid of an $18.2 million, five-year grant renewal from the National Institute on Aging, the Vanderbilt Memory and Aging Project (VMAP) will advance interdisciplinary research into abnormal brain aging and cognitive decline in older adults, with continuing emphasis on the role of blood flow changes in the heart and brain.

By Paul Govern
July 20, 2020

Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

By Bill Snyder
photo of David Charles and Mallory Hacker
June 30, 2020

Pilot study suggests Parkinson’s disease progression can be slowed

A pair of ultra-thin electrodes surgically implanted deep into the brain might slow the progression of Parkinson’s disease, according to five-year outcomes from a 30-patient randomized clinical trial conducted by investigators at Vanderbilt University Medical Center.

By Paul Govern
June 23, 2020

A connection to schizophrenia

The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.

By Bill Snyder
June 22, 2020

Single mutation causes seizure disorder

A single mutation in one gene can impair inhibitory signaling in the brain and cause multiple types of seizures and behavioral abnormalities.
By Leigh MacMillan
May 7, 2020

Project seeks to help adults with TBI access social media

With more than $2 million in funding, researchers from Vanderbilt University Medical Center are developing software to make social media platforms more accessible for adults with cognitive disabilities.
By Kelsey Herbers
May 7, 2020

New study examines Alzheimer’s disease images and molecular biomarkers

Alzheimer’s disease (AD) involves distinctive wasting away of certain brain regions, such that medical imaging of these regions can distinguish the disease from other subtypes of dementia.
By Paul Govern
May 7, 2020

Study to explore memory system’s role in TBI behavior deficits

VUMC researchers are beginning a new five-year study to characterize the role of a memory system in behavioral deficits commonly seen in individuals with traumatic brain injury (TBI).
By Kelsey Herbers
April 1, 2020

Study to explore TBI’s impact on language processing

Researchers from Vanderbilt University Medical Center and Vanderbilt University have been awarded more than $3.8 million to study the impact of traumatic brain injury (TBI) on one’s ability to process language in everyday settings.
By Kelsey Herbers
February 12, 2020

Study seeks link between menopause, Alzheimer’s

Beginning this month, researchers from VUMC and the University of Vermont are launching a study to examine whether cognitive changes that occur at menopause for some women are related to an increased risk for Alzheimer's disease.
By Kelsey Herbers
December 12, 2019

Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.
By Bill Snyder
1 … 3 4 5 6 7 … 17